[Abortive properties of tetracyclines in mice. Hormone treatments].
D000014:Abnormalities, Drug-Induced / Q000473:pathology; D000022:Abortion, Spontaneous / Q000139:chemically induced*; D000033:Abortion, Threatened / Q000188:drug therapy; D000818:Animals; D002751:Chlortetracycline / Q000009:adverse effects; D010064:Embryo Implantation / Q000187:drug effects*; D004717:Endometrium / Q000473:pathology; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000494:pharmacology; D007986:Luteinizing Hormone / Q000494:pharmacology; D051379:Mice; D010053:Ovary / Q000187:drug effects; D011247:Pregnancy; D011374:Progesterone / Q000494:pharmacology; D011388:Prolactin / Q000627:therapeutic use; D013752:Tetracycline / Q000009:adverse effects*; D013997:Time Factors; D014626:Vaginal Smears
D011374:Progesterone; D004958:Estradiol; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013752:Tetracycline; D002751:Chlortetracycline
Propriétés abortives des tetracyclines chez la souris. Traitements hormonaux.